| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Hepatitis Be Panel : 27
Test CodeQHBEB or 27
CPT Codes
86707, 87350
Includes
Hepatitis Be Antibody and Hepatitis Be Antigen
Instructions
Dietary supplements containing biotin may interfere in assays and may skew analyte results to be either falsely high or falsely low. For patients receiving the recommended daily doses of biotin, draw samples at least 8 hours following the last biotin supplementation. For patients on mega-doses of biotin supplements, draw samples at least 72 hours following the last biotin supplementation.
Transport Container
Specimen:
2 mL serum
Minimum Volume: 1 mL
2 mL serum
Minimum Volume: 1 mL
Transport Temperature
Room temperature.
Specimen Stability
Room Temperature: 7 days; Refrigerated: 14 days; Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis, grossly lipemic, plasma
Methodology
Immunoassay
Setup Schedule
Sunday - Saturday
Report Available
2-3 days (From receipt at performing laboratory)
Reference Range
Non-Reactive
Clinical Significance
HBeAb appears in the early convalescence of HBV infection. With carrier state and chronic hepatitis, HBeAb may not develop.
HBeAg indicates active HBV replication. Infectivity is evaluated based on HBeAg and HBsAg. When HBeAg persists much longer than 10 weeks, the patient is likely to develop chronic hepatitis and be a carrier.
HBeAg indicates active HBV replication. Infectivity is evaluated based on HBeAg and HBsAg. When HBeAg persists much longer than 10 weeks, the patient is likely to develop chronic hepatitis and be a carrier.
Performing Laboratory
Quest Diagnostics
